Patents by Inventor Minseon Jeong

Minseon Jeong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED THIAZOLIDINEDIONE DERIVATIVE COMPOUND, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME
    Publication number: 20250066347
    Abstract: The present invention relates to: a substituted thiazolidinedione derivative compound having a novel structure acting as a sterol regulatory element-binding protein-1 (SREBP1) inhibitor, a hydrate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating cancer, comprising same as an active ingredient.
    Type: Application
    Filed: December 19, 2022
    Publication date: February 27, 2025
    Inventors: Jun-Kyum KIM, Jia CHOI, Eun-Jung KIM, Cheol-Kyu PARK, Seok Won HAM, Min Gi PARK, Hyeon Ju JEONG, Sung Jin KIM, Kyungim MIN, Jong Min PARK, Jungwook CHIN, Sung Jin CHO, Jina KIM, Kyung Jin JUNG, Nayeon KIM, Suhui KIM, Sugyeong KWON, Su-Jeong LEE, Minseon JEONG, Hongchan AN, Jeong-Eun PARK, Dong-Hyun KIM, Ji-youn LIM, Ju-sik MIN, Ji Sun HWANG, Hyo-Jung CHOI, Hayoung HWANG, Oh-Bin KWON, Sungwoo LEE, Sang Bum KIM
  • NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE
    Publication number: 20220194928
    Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.
    Type: Application
    Filed: March 10, 2022
    Publication date: June 23, 2022
    Inventors: Soon Jun Hong, Chung Ho Kim, Hyung Joon Joo, Jong-Ho Kim, Ji-Young Park, Seung Cheol Choi, Chan-Sik Yang, Jong Hwa Jung, Minseon Jeong, Miseon Ryu, Sugyeong Kwon
  • N-acylurea derivative and composition comprising same for prevention or treatment of cardiovascular disease
    Patent number: 11306073
    Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: April 19, 2022
    Assignees: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION, KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERTION FOUNDATION
    Inventors: Soon Jun Hong, Chung Ho Kim, Hyung Joon Joo, Jong-Ho Kim, Ji-Young Park, Seung Cheol Choi, Chan-Sik Yang, Jong Hwa Jung, Minseon Jeong, Miseon Ryu, Sugyeong Kwon
  • NOVEL N-ACYLUREA DERIVATIVE AND COMPOSITION COMPRISING SAME FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASE
    Publication number: 20190119261
    Abstract: The present invention relates to a novel N-acylurea derivative and the use thereof for the prevention or treatment of cardiovascular disease, and more particularly to a novel N-acylurea derivative, a pharmaceutical composition for prevention or treatment of cardiovascular disease, which contains the N-acylurea derivative as an active ingredient, and a method of preparing the N-acylurea derivative. The N-acylurea derivative according to the present invention can inhibit platelet aggregation by inhibiting the activity of talin in the intracellular matrix, and thus can be useful for the prevention or treatment of cardiovascular disease.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 25, 2019
    Inventors: Soon Jun Hong, Chung Ho Kim, Hyung Joon Joo, Jong-Ho Kim, Ji-Young Park, Seung Cheol Choi, Chan-Sik Yang, Jong Hwa Jung, Minseon Jeong, Miseon Ryu, Sugyeong Kwon